Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Cantel Medical (CMD) Share Price

Headlines about Cantel Medical (NYSE:CMD) have trended somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cantel Medical earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 44.7716033154351 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Cantel Medical (NYSE:CMD) traded up $3.57 during trading on Friday, hitting $106.63. 190,841 shares of the stock were exchanged, compared to its average volume of 133,587. Cantel Medical has a one year low of $69.21 and a one year high of $116.79. The stock has a market capitalization of $4,308.51, a price-to-earnings ratio of 58.91 and a beta of 1.26. The company has a current ratio of 2.44, a quick ratio of 1.48 and a debt-to-equity ratio of 0.31.

Cantel Medical (NYSE:CMD) last released its quarterly earnings results on Thursday, December 7th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. Cantel Medical had a net margin of 9.50% and a return on equity of 17.42%. sell-side analysts anticipate that Cantel Medical will post 2.35 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Cantel Medical (CMD) Share Price” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://ledgergazette.com/2018/02/11/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-cantel-medical-cmd-share-price.html.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply